Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
iShares U.S. Pharmaceuticals ETF (IHE) and State Street Health Care Select Sector SPDR ETF (XLV) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. IHE is more expensive with a Total Expense Ratio (TER) of 0.38%, versus 0.08% for XLV. IHE is up 4.3% year-to-date (YTD) with +$129M in YTD flows. XLV performs worse with -1.22% YTD performance, and +$922M in YTD flows. Run a side-by-side ETF comparison of IHE and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IHE XLV | -1.82%-2.18% | +5.93%-0.02% | +4.30%-1.22% | +28.47%+6.49% | +63.32%+28.22% | +61.21%+44.77% |
| Flows | IHE XLV | +$9M-$726M | +$154M+$102M | +$129M+$922M | +$248M+$101M | +$359M-$4.93B | +$393M+$6.94B |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IHE XLV | +15.86%+13.57% | +20.40%+17.40% | +15.94%+13.59% | +15.80%+14.47% |
| Max drawdown | IHE XLV | -4.49%-4.63% | -14.18%-12.43% | -16.04%-17.05% | -16.12%-17.05% |
| Max drawdown duration | IHE XLV | 10d10d | 150d211d | 210d444d | 669d444d |
IHE | XLV | |
Last sale 3/12/2026 at 1:30 PM | $86.66 | $150.17 |
| Previous close 03/11/2026 | $88.40 | $152.85 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IHE | XLV | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IHE | XLV | |
|---|---|---|
| Last price | $86.66 | $150.17 |
| 1D performance | -1.97% | -1.75% |
| AuM | $1.02 B | $40.10 B |
| E/R | 0.38% | 0.08% |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
